Clinical trials
Withdrawn Phase 1 Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atara Biotherapeutics | 1 |
| Beijing Boren Hospital | 1 |
| Boehringer Ingelheim | 1 |
| Calibr, a division of Scripps Research | 1 |
| Caribou Biosciences, Inc. | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| Nanjing Legend Biotech Co. | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 16 |
| Autoimmune Diseases | 4 |
| Myositis | 4 |
| Lupus Nephritis | 3 |
| Scleroderma, Systemic | 3 |
| Recurrence | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Epstein-Barr Virus Infections | 1 |
| Immunoglobulin G4-Related Disease | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.